home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  November 14, 2018
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 549 active entries

Hubei Lansun Biochemistry Pharmaceutical Co., Ltd.

No. 81 Pengcheng Avenue, new industrial district o
huangshi,435000
China

Phone: 867146395977
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

Hubei Lansun Biochemistry Pharmaceutical Co., Ltd. specializes in APIs pharmaceutical production,including Cephalosporin intermediate ,antineoplastic drug,senile dementia drug, Central nervous system drugs, Antispasmodic and analgesic drugs and gastrointestinal drug. We also produce according to our customers' requirements and specifications.

we have invested 150 million Yuan (equivalent to 24.68 million USD) to establish 2 common API plants, 1 cephalosporin API plant and an antineoplastic API plant with auxiliary facilities such as offices, warehouses, water supply, electricity and waste water treatment.. The facilities cover an area of 36,000 square meters and compliant with Chinese SFDA (State Food and Drug Administration) GMP requirements. The facilities have the manufacturing capability of 50 tons of APIs and intermediates for cardiovascular, antineoplastic, antibiotic, etc. 

 Lansun Biochemistry has a strong management team and R&D. We can not only supply you high quality product but also give you specialized solutions. We will evolve together with you to provide the patients a perfect life.



Selected Categories:
Product Company   Service Company
Pharmaceutical
- General

Last update of this entry: March 05, 2014

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.